|
VUMC implementation |
Colorectal Cancer (CRC) |
Vanderbilt University Medical Center |
Case, Control |
|
|
|
|
|
RBC Northwestern Implementation |
Red Blood Cell Indices |
Northwestern University |
Case Only |
|
|
98% |
91% |
|
CHOP eMERGE III |
Migraine |
CHOP |
Case, Control |
|
|
|
|
|
VU E3 implementation |
Clostridium Difficile Colitis |
Vanderbilt University Medical Center |
Case, Control |
|
|
|
|
|
NU eMERGE pneumonia data |
Pneumonia- VUMC eMERGE v5.1 |
Northwestern University |
Case, Control |
|
|
|
|
|
Mayo Clinic CAAD Evaluation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Mayo Clinic |
Case, Control |
|
|
100% |
72% |
|
CHOP NAFLD |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
CHOP |
Case Only |
12 |
|
100% |
|
|
Cardiac Conduction Marshfield Implementation |
Cardiac Conduction (QRS) |
Marshfield Clinic Research Foundation |
Case Only |
|
|
100% |
|
|
Columbia Depression Implementation |
Depression |
Columbia University Medical Center |
Case, Control |
|
|
|
|
|
NU appendicitis cases |
Appendicitis |
Northwestern University |
Case Only |
30 |
|
100% |
|
|
Mayo SLE Implementation |
SLE (Systemic Lupus Erythematosus) using SLICC (Systemic Lupus Internation Collaborating Clinics) Criteria |
Mayo Clinic |
Case, Control |
0 |
0 |
|
|
|
CHOP Post-event Pain |
Post-event Pain algorithm |
CHOP |
Case, Control |
99 |
2 |
96% |
|
|
Early Childhood Obesity Implementation - Columbia |
Severe Early Childhood Obesity |
Columbia University |
Case, Control |
2 |
3 |
|
|
|
Marshfield Zoster implementation |
Herpes Zoster |
Marshfield Clinic Research Foundation |
Case, Control |
10 |
10 |
100%, 100% |
|
|
Validation of Asthma algorithm - Geisinger |
Asthma |
Geisinger |
Case, Control |
10 |
10 |
100%, 100% |
|
|
Marshfield C-diff implementation |
Clostridium Difficile Colitis |
Marshfield Clinic Research Foundation |
Case, Control |
21 |
10 |
100%, 100% |
|
|
Appendicitis Case 1, Control |
Appendicitis |
Cincinnati Children's Hospital Medical Center |
Case, Control |
15 |
20 |
93%, 100% |
|
|
Geisinger c.Diff eMERGE3 Implementation |
Clostridium Difficile Colitis |
Geisinger |
Case, Control |
20 |
20 |
100%, 100% |
100%, 100% |
|
Marshfield AAA implementation |
Abdominal Aortic Aneurysm ( AAA ) |
Marshfield Clinic Research Foundation |
Case, Control |
25 |
22 |
100%, 100% |
|
|
Group Health and UW Zoster Implementation |
Herpes Zoster |
Group Health and UW |
Case, Control |
25 |
25 |
100%, 96% |
100% |
|
Marshfield Hearing loss validation |
Hearing Loss |
Marshfield Clinic Research Foundation |
Case, Control |
25 |
25 |
100%, 100% |
|
|
Group Health/University of Washington CRC Validation |
Colorectal Cancer (CRC) |
GH/UW |
Case, Control |
25 |
25 |
92%, 100% |
100%, 100% |
|
Statin and MACE Mount Sinai Implementation |
Statins and MACE |
Mount Sinai |
Case Only |
52 |
25 |
96%, 100% |
100%, 100% |
|
Marshfield ACE-I cough implentation |
ACE Inhibitor (ACE-I) induced cough |
Marshfield Clinic Research Foundation |
Case, Control |
25 |
25 |
100%, 96% |
|
|
Implementation For Phase 3 eMERGE |
Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia |
Geisinger |
Case, Control |
25 |
25 |
100%, 96% |
|
